Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparative review of the carbapenems.
Zhanel GG, Wiebe R, Dilay L, Thomson K, Rubinstein E, Hoban DJ, Noreddin AM, Karlowsky JA. Zhanel GG, et al. Among authors: noreddin am. Drugs. 2007;67(7):1027-52. doi: 10.2165/00003495-200767070-00006. Drugs. 2007. PMID: 17488146 Review.
Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin.
Zhanel GG, Lam A, Schweizer F, Thomson K, Walkty A, Rubinstein E, Gin AS, Hoban DJ, Noreddin AM, Karlowsky JA. Zhanel GG, et al. Among authors: noreddin am. Am J Clin Dermatol. 2008;9(4):245-54. doi: 10.2165/00128071-200809040-00004. Am J Clin Dermatol. 2008. PMID: 18572975 Review.
The glycylcyclines: a comparative review with the tetracyclines.
Zhanel GG, Homenuik K, Nichol K, Noreddin A, Vercaigne L, Embil J, Gin A, Karlowsky JA, Hoban DJ. Zhanel GG, et al. Among authors: noreddin a. Drugs. 2004;64(1):63-88. doi: 10.2165/00003495-200464010-00005. Drugs. 2004. PMID: 14723559 Review.
Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
Zhanel GG, Voth D, Nichol K, Karlowsky JA, Noreddin AM, Hoban DJ. Zhanel GG, et al. Among authors: noreddin am. J Antimicrob Chemother. 2009 Aug;64(2):364-9. doi: 10.1093/jac/dkp176. Epub 2009 May 19. J Antimicrob Chemother. 2009. PMID: 19454524
Ceftaroline pharmacodynamic activity versus community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus, heteroresistant vancomycin-intermediate S. aureus, vancomycin-intermediate S. aureus and vancomycin-resistant S. aureus using an in vitro model.
Zhanel GG, Rossnagel E, Nichol K, Cox L, Karlowsky JA, Zelenitsky S, Noreddin AM, Hoban DJ. Zhanel GG, et al. Among authors: noreddin am. J Antimicrob Chemother. 2011 Jun;66(6):1301-5. doi: 10.1093/jac/dkr110. Epub 2011 Mar 23. J Antimicrob Chemother. 2011. PMID: 21429940
Assessment of the activity of ceftaroline against clinical isolates of penicillin-intermediate and penicillin-resistant Streptococcus pneumoniae with elevated MICs of ceftaroline using an in vitro pharmacodynamic model.
Zhanel GG, Yachison C, Nichol K, Adam H, Noreddin AM, Hoban DJ, Karlowsky JA. Zhanel GG, et al. Among authors: noreddin am. J Antimicrob Chemother. 2012 Jul;67(7):1706-11. doi: 10.1093/jac/dks113. Epub 2012 Mar 30. J Antimicrob Chemother. 2012. PMID: 22467630
The ketolides: a critical review.
Zhanel GG, Walters M, Noreddin A, Vercaigne LM, Wierzbowski A, Embil JM, Gin AS, Douthwaite S, Hoban DJ. Zhanel GG, et al. Among authors: noreddin a. Drugs. 2002;62(12):1771-804. doi: 10.2165/00003495-200262120-00006. Drugs. 2002. PMID: 12149046 Review.
73 results